UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease

The Journal of immunology (1950), 2008-09, Vol.181 (6), p.4397-4405

2008

Volltextzugriff (PDF)

Increased Generation of Fibrocytes in Thyroid-Associated Ophthalmopathy

The journal of clinical endocrinology and metabolism, 2010-01, Vol.95 (1), p.430-438

2010

Volltextzugriff (PDF)

Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer

European thyroid journal, 2024-02, Vol.13 (1), p.1-13

2024

Volltextzugriff (PDF)

Prolonged duration of response in lenvatinib responders with thyroid cancer

Endocrine-related cancer, 2018-06, Vol.25 (6), p.699-704

2018

Volltextzugriff (PDF)

Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm

Thyroid (New York, N.Y.), 2017-08, Vol.27 (8), p.994-1000

2017

Volltextzugriff (PDF)

Health‐related quality‐of‐life analyses from a multicenter, randomized, double‐blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day

Cancer medicine (Malden, MA), 2023-02, Vol.12 (4), p.4332-4342

2023

Volltextzugriff (PDF)

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

The New England journal of medicine, 2015-02, Vol.372 (7), p.621-630

2015

Volltextzugriff (PDF)

Management of severe thyrotoxicosis when the gastrointestinal tract is compromised

Thyroid (New York, N.Y.), 2011-03, Vol.21 (3), p.215-220

2011

Volltextzugriff (PDF)

Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy

Thyroid (New York, N.Y.), 2008-09, Vol.18 (9), p.983-988

2008

Volltextzugriff (PDF)

A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2022-02, Vol.107 (3), p.776-787

2022

Volltextzugriff (PDF)

Thyroglobulin antibody status and differentiated thyroid cancer: what does it mean for prognosis and surveillance?

Current opinion in oncology, 2015-01, Vol.27 (1), p.26-32

Gianoukakis, Andrew G

2015

Volltextzugriff (PDF)

Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)

Journal of clinical oncology, 2022-06, Vol.40 (17), p.1870-1878

2022

Volltextzugriff (PDF)

Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes

Endocrine, 2017-04, Vol.56 (1), p.121-128

2017

Volltextzugriff (PDF)

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers

Clinical cancer research, 2024-09, Vol.30 (17), p.3757-3767

2024

Volltextzugriff (PDF)

Parity and Risk of Thyroid Autoimmunity Based on the NHANES (2001–2002, 2007–2008, 2009–2010, and 2011–2012)

The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3437-3442

2017

Volltextzugriff (PDF)

Cytokines, Graves' disease, and thyroid-associated ophthalmopathy

Thyroid (New York, N.Y.), 2008-09, Vol.18 (9), p.953-958

2008

Volltextzugriff (PDF)

Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer

Endocrine, 2022-05, Vol.76 (2), p.491-494

2022

Volltextzugriff (PDF)

Well differentiated follicular thyroid neoplasia: Impact of molecular and technological advances on detection, monitoring and treatment

Molecular and cellular endocrinology, 2011-01, Vol.332 (1-2), p.9-20

2011

Volltextzugriff (PDF)

Response to Rosário and Souza Côrtes re: "The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence"

Thyroid (New York, N.Y.), 2020-11, Vol.30 (11), p.1686-1687

2020

Volltextzugriff (PDF)

Familial adenomatous polyposis-associated, cribriform morular variant of papillary thyroid carcinoma harboring a K-RAS mutation: case presentation and review of molecular mechanisms

Thyroid (New York, N.Y.), 2014-07, Vol.24 (7), p.1184-1189

2014

Volltextzugriff (PDF)

The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence

Thyroid (New York, N.Y.), 2020-10, Vol.30 (10), p.1490-1495

2020

Volltextzugriff (PDF)

Aberrant Expression of the Insulin-Like Growth Factor-1 Receptor by T Cells from Patients with Graves' Disease May Carry Functional Consequences for Disease Pathogenesis

Journal of Immunology, 2007-03, Vol.178 (5), p.3281-3287

2007

Volltextzugriff (PDF)

Pancreatic Neuroendocrine Tumors

Endocrine research, 2011, Vol.36 (1), p.35-43

2011

Volltextzugriff (PDF)

B Cells from Patients with Graves' Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis

The Journal of immunology (1950), 2008-10, Vol.181 (8), p.5768-5774

2008

Volltextzugriff (PDF)

Fibroblasts Expressing the Thyrotropin Receptor Overarch Thyroid and Orbit in Graves' Disease

The journal of clinical endocrinology and metabolism, 2011-12, Vol.96 (12), p.3827-3837

2011

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEndocrine Practice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(37)
Endocrinology & Metabolism
(25)
Female
(16)
Male
(12)
Adult
(10)
Middle Aged
(10)
Biological And Medical Sciences
(8)
Cells, Cultured
(8)
Thyroid Cancer
(8)
Aged
(7)
Fibroblasts - Metabolism
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Graves Disease - Immunology
(7)
Graves Disease - Pathology
(7)
Oncology
(7)
Thyroid Neoplasms - Drug Therapy
(7)
Iodine Radioisotopes - Therapeutic Use
(6)
Thyroid Gland - Metabolism
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease

Increased Generation of Fibrocytes in Thyroid-Associated Ophthalmopathy

Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer

Prolonged duration of response in lenvatinib responders with thyroid cancer

Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm

Health‐related quality‐of‐life analyses from a multicenter, randomized, double‐blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

Management of severe thyrotoxicosis when the gastrointestinal tract is compromised

Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy

A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

Thyroglobulin antibody status and differentiated thyroid cancer: what does it mean for prognosis and surveillance?

Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)

Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers

Parity and Risk of Thyroid Autoimmunity Based on the NHANES (2001–2002, 2007–2008, 2009–2010, and 2011–2012)

Cytokines, Graves' disease, and thyroid-associated ophthalmopathy

Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer

Well differentiated follicular thyroid neoplasia: Impact of molecular and technological advances on detection, monitoring and treatment

Response to Rosário and Souza Côrtes re: "The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence"

Familial adenomatous polyposis-associated, cribriform morular variant of papillary thyroid carcinoma harboring a K-RAS mutation: case presentation and review of molecular mechanisms

The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence

Aberrant Expression of the Insulin-Like Growth Factor-1 Receptor by T Cells from Patients with Graves' Disease May Carry Functional Consequences for Disease Pathogenesis

Pancreatic Neuroendocrine Tumors

B Cells from Patients with Graves' Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis

Fibroblasts Expressing the Thyrotropin Receptor Overarch Thyroid and Orbit in Graves' Disease

Aktive Filter

Suchergebnisse filtern